UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Issuer's telephone number) For the quarter ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39136 Helbiz, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of i ...

[Explanatory Note](index=3&type=section&id=EXPLANATORY%20NOTE) This section clarifies the Company's identity and the timing of the Helbiz Holdings acquisition relative to the reporting period - Helbiz, Inc. (formerly GreenVision Acquisition Corp.) consummated the acquisition of Helbiz Holdings, Inc. on **August 12, 2021**, subsequent to the fiscal quarter ended June 30, 2021[7](index=7&type=chunk)[8](index=8&type=chunk) - GRNV acquired all outstanding Helbiz Holdings shares in exchange for **10,271,729 shares of Class A Common Stock**, **14,225,867 shares of Class B Common Stock**, and **7,409,685 options** to acquire Class A Common Stock[8](index=8&type=chunk) - Each Helbiz Holdings share was converted into the right to receive **4.63 GRNV shares** of the respective class[9](index=9&type=chunk) - References to 'we,' 'us,' 'our,' or the 'Company' in this report refer to the registrant prior to the closing of the Business Combination, as the report covers a period before the merger[10](index=10&type=chunk)[11](index=11&type=chunk) [Part I. Financial Information](index=5&type=section&id=Part%20I.%20Financial%20Information) This part presents the Company's unaudited condensed consolidated financial statements and management's analysis of its financial condition and operations [Item 1. Unaudited Financial Statements](index=5&type=section&id=Item%201.%20Unaudited%20Financial%20Statements) This section presents the unaudited condensed consolidated financial statements, including balance sheets, statements of operations, changes in stockholders' equity, and cash flows, along with detailed notes [Condensed Consolidated Balance Sheets](index=5&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) This statement provides a snapshot of the Company's assets, liabilities, and equity as of June 30, 2021, and December 31, 2020 | Metric | June 30, 2021 (Unaudited) | December 31, 2020 | | :-------------------------------- | :------------------------ | :---------------- | | Cash | $20,089 | $4,282 | | Prepaid expenses and other current assets | $77,439 | $18,429 | | Total Current Assets | $97,528 | $22,711 | | Marketable securities held in Trust Account | $19,525,546 | $58,390,918 | | TOTAL ASSETS | $19,623,074 | $58,413,629 | | Accounts payable and accrued expenses | $371,170 | $313,347 | | Advance from third party | $570,935 | $20,000 | | Total Current Liabilities | $942,105 | $333,347 | | Warrant Liability | $3,316,288 | $3,077,863 | | Total Liabilities | $4,258,393 | $3,411,210 | | Common stock subject to possible redemption | $19,475,546 | $50,002,415 | | Total Stockholders' (Deficit) Equity | $(4,110,865) | $5,000,004 | [Condensed Consolidated Statements of Operations](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) This statement details the Company's revenues, expenses, and net loss for the three and six months ended June 30, 2021, and 2020 Three Months Ended June 30 | Metric | 2021 | 2020 | | :--------------------------------------- | :----------- | :----------- | | Operating and formation costs | $500,336 | $197,910 | | Loss from operations | $(500,336) | $(197,910) | | Interest earned on marketable securities held in Trust Account | $982 | $14,418 | | Change in fair value of private warrants liability | $(18,850) | $(48,014) | | Net (loss) income | $(518,204) | $(192,972) | | Basic and diluted net (loss) income per common share | $(0.36) | $(0.09) | Six Months Ended June 30 | Metric | 2021 | 2020 | | :--------------------------------------- | :------------ | :----------- | | Operating and formation costs | $769,628 | $354,799 | | Loss from operations | $(769,628) | $(354,799) | | Interest earned on marketable securities held in Trust Account | $2,430 | $340,029 | | Change in fair value of private warrants liability | $(238,425) | $381,761 | | Net (loss) income | $(1,005,623) | $370,093 | | Basic and diluted net (loss) income per common share | $(0.58) | $0.07 | [Condensed Consolidated Statements Changes in Stockholders' Equity](index=7&type=section&id=Condensed%20Consolidated%20Statements%20Changes%20in%20Stockholders'%20Equity) This statement outlines the changes in the Company's stockholders' equity over the six months ended June 30, 2021 Total Stockholders' (Deficit) Equity | Date | Total Stockholders' (Deficit) Equity | | :----------------- | :----------------------------------- | | January 1, 2021 | $5,000,004 | | March 31, 2021 | $(3,676,411) | | June 30, 2021 | $(4,110,865) | - The change in value of common stock subject to possible redemption significantly impacted equity, decreasing by **$8,763,996** from January 1 to March 31, 2021, and increasing by **$83,570** from March 31 to June 30, 2021[23](index=23&type=chunk) - Net losses of **$487,419** and **$518,204** were recorded for the periods ending March 31, 2021, and June 30, 2021, respectively[23](index=23&type=chunk) [Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) This statement summarizes the cash inflows and outflows from operating, investing, and financing activities for the six months ended June 30, 2021, and 2020 Cash Flow Summary (Six Months Ended June 30) | Metric | 2021 | 2020 | | :--------------------------------------- | :------------- | :----------- | | Net (loss) income | $(1,005,623) | $370,093 | | Net cash used in operating activities | $(770,815) | $(361,093) | | Net cash provided by investing activities | $38,867,802 | $92,080 | | Net cash used in financing activities | $(38,081,180) | $0 | | Net Change in Cash | $15,807 | $(269,013) | | Cash – Ending | $20,089 | $202,271 | [Notes to Unaudited Condensed Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20Unaudited%20Condensed%20Consolidated%20Financial%20Statements) This section provides detailed explanations and disclosures supporting the unaudited condensed consolidated financial statements - Helbiz, Inc. (formerly GreenVision Acquisition Corp.) completed the acquisition of Helbiz Holdings, Inc. on **August 12, 2021**, after the reporting period[31](index=31&type=chunk) - The Company received a Nasdaq notice on **January 5, 2021**, for non-compliance with Rule 5620(a) (failure to hold an annual meeting) and was granted an extension until **June 29, 2021**[41](index=41&type=chunk) - On **August 16, 2021**, a delisting notice was received for not meeting initial listing requirements, and an appeal was filed[43](index=43&type=chunk) - The Company is an 'emerging growth company' and has elected to use the extended transition period for complying with new or revised financial accounting standards[50](index=50&type=chunk)[51](index=51&type=chunk) - Private Warrants are classified as liabilities at fair value and re-measured each reporting period, with changes recognized in the statement of operations[57](index=57&type=chunk) - Common stock subject to possible redemption is classified as temporary equity at redemption value due to redemption rights outside the Company's control[58](index=58&type=chunk) - The Company received working capital loans totaling **$9,000** from the Sponsor and **$367,000** from Helbiz, Inc. as of June 30, 2021, with an additional **$28,000** from Helbiz on July 15, 2021[80](index=80&type=chunk)[83](index=83&type=chunk) - The Company funded **$575,000** into the Trust Account to extend the business combination period to **May 21, 2021**, and further extended it to **August 19, 2021**, with potential for two additional three-month extensions, each requiring a **$191,155.30** deposit[85](index=85&type=chunk)[86](index=86&type=chunk) - On **March 10, 2021**, GreenVision entered into subscription agreements for a **$30,000,000 PIPE investment** (**3,000,000 shares** and **3,000,000 warrants**) contingent on the Business Combination[108](index=108&type=chunk) - Former Helbiz Holdings securityholders (owning at least **75,000 shares**) are subject to lock-up agreements for **6 to 12 months** post-Business Combination[112](index=112&type=chunk) - The Founder agreed to indemnify Helbiz for specified losses, with **1,600,000 shares** of Helbiz Class B common stock deposited into a third-party escrow account as security[113](index=113&type=chunk) Fair Value Measurements (June 30, 2021) | Description | Level | Fair Value | | :-------------------------------- | :---- | :----------- | | Marketable securities held in Trust Account | 1 | $19,525,546 | | Warrant liability – Private Warrants | 3 | $3,049,200 | | Warrant liability – Underwriter Warrants | 3 | $267,088 | - On **August 12, 2021**, the merger was consummated[137](index=137&type=chunk) - GRNV stockholders redeemed **1,615,502 shares**[137](index=137&type=chunk) - The PIPE Investment closed for **$26.5 million** (below the **$30 million** minimum, which was waived), with **$5 million** in the form of debt cancellation[138](index=138&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=30&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) This section provides management's perspective on the Company's financial condition and operational results, emphasizing its status as a blank check company prior to the Helbiz Business Combination [Overview](index=30&type=section&id=Overview) This section provides a brief introduction to the Company's formation and purpose as a blank check company - Helbiz, Inc. (formerly GreenVision Acquisition Corp.) was formed on **September 11, 2019**, as a blank check company to effect a business combination[142](index=142&type=chunk) [Recent Developments](index=30&type=section&id=Recent%20Developments) This section outlines key events including the Helbiz Merger Agreement, PIPE investment, Nasdaq listing issues, and financial restatements - On **February 8, 2021**, the Company entered into the Helbiz Merger Agreement, valuing Helbiz at **$300,000,000** minus 'Closing Net Debt,' with consideration in Class A and Class B Common Stock[143](index=143&type=chunk) - On **March 10, 2021**, GreenVision entered into subscription agreements for a **$30,000,000 PIPE investment** (**3,000,000 shares** and **3,000,000 warrants**) contingent on the Business Combination[146](index=146&type=chunk) - The Company received a delisting notice from Nasdaq on **August 16, 2021**, for not meeting initial listing requirements and filed an appeal[150](index=150&type=chunk) - In connection with the extension amendment, **3,838,447 shares** were redeemed for approximately **$39.2 million**, leaving **$19.5 million** in the trust account[151](index=151&type=chunk) - The Company restated its historical financial statements to reclassify Private Warrants as derivative liabilities pursuant to ASC 815-40[152](index=152&type=chunk)[153](index=153&type=chunk) [Results of Operations](index=33&type=section&id=Results%20of%20Operations) This section analyzes the Company's net losses for the three and six months ended June 30, 2021, driven by operating costs and warrant fair value changes - The Company has not engaged in any operations or generated any revenues to date, expecting to do so only after the completion of its Business Combination[154](index=154&type=chunk) - Net loss for the three months ended June 30, 2021, was **$518,204**, primarily due to operating costs (**$500,336**) and change in fair value of warrant liability (**$18,850**), offset by interest income (**$982**)[155](index=155&type=chunk) - Net loss for the six months ended June 30, 2021, was **$1,005,623**, primarily due to operating costs (**$769,628**) and change in fair value of warrant liability (**$238,425**), offset by interest income (**$2,430**)[156](index=156&type=chunk) - Interest income on marketable securities held in the Trust Account significantly decreased in 2021 due to the redemption of **3,838,447 shares** for **$39,207,114**[155](index=155&type=chunk)[156](index=156&type=chunk) [Liquidity and Capital Resources](index=33&type=section&id=Liquidity%20and%20Capital%20Resources) This section discusses the Company's cash position, trust account balance, working capital loans, and going concern considerations - The Initial Public Offering generated **$57,500,000**, and the sale of Private Warrants generated **$2,100,000**[159](index=159&type=chunk) - As of June 30, 2021, **$19,525,546** remained in the Trust Account, significantly reduced from the initial **$57,500,000** due to redemptions[164](index=164&type=chunk) - The Company had **$20,089** of cash held outside the Trust Account as of June 30, 2021, for working capital and business combination expenses[165](index=165&type=chunk) - Working capital loans totaling **$9,000** were received from the Sponsor, and **$367,000** from Helbiz, Inc. (with an additional **$28,000** post-period) to fund operations[166](index=166&type=chunk)[167](index=167&type=chunk) - Substantial doubt exists about the Company's ability to continue as a going concern through **August 19, 2021**, without additional financing or a completed Business Combination[168](index=168&type=chunk) [Off-Balance Sheet Arrangements](index=35&type=section&id=Off-Balance%20Sheet%20Arrangements) This section confirms the absence of any off-balance sheet arrangements as of June 30, 2021 - The Company did not have any off-balance sheet arrangements as of June 30, 2021[170](index=170&type=chunk) [Contractual Obligations](index=35&type=section&id=Contractual%20Obligations) This section details the Company's lack of long-term debt or lease obligations and outlines a contingent cash fee for advisory services - The Company has no long-term debt, capital lease obligations, operating lease obligations, or long-term liabilities[171](index=171&type=chunk) - A cash fee of **$1,437,500** is payable to I-Bankers Securities, Inc. upon the consummation of a Business Combination for advisory services[172](index=172&type=chunk) [Critical Accounting Policies](index=35&type=section&id=Critical%20Accounting%20Policies) This section describes the Company's key accounting policies for redeemable common stock, earnings per share, fair value measurements, and derivative instruments - Common stock subject to possible redemption is classified as temporary equity at redemption value due to redemption rights outside the Company's control[174](index=174&type=chunk) - The Company applies the two-class method for calculating earnings per share, distinguishing between redeemable and non-redeemable common stock[175](index=175&type=chunk) - Fair value measurements utilize a three-tier hierarchy (Level 1, 2, 3) based on the observability of inputs[176](index=176&type=chunk)[177](index=177&type=chunk) - Derivative financial instruments are recorded as liabilities at fair value and re-valued each reporting period, with changes recognized in the statements of operations[179](index=179&type=chunk) [Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk](index=36&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20Regarding%20Market%20Risk) This section assesses the Company's exposure to market risks, particularly interest rate risk, given its investments in the Trust Account - The Company's investments in the Trust Account are in short-term U.S. government treasury bills or money market funds, resulting in no material exposure to interest rate risk[181](index=181&type=chunk) [Item 4. Controls and Procedures](index=36&type=section&id=Item%204.%20Controls%20and%20Procedures) This section reports on the ineffectiveness of disclosure controls and procedures due to material weaknesses in accounting for complex securities and related disclosures - The Chief Executive Officer and Chief Financial Officer concluded that the Company's disclosure controls and procedures were **ineffective** as of June 30, 2021[183](index=183&type=chunk) - Material weaknesses identified include: (i) incorrect classification of Private Warrants as equity instead of derivative liabilities, (ii) inadvertent non-disclosure of PIPE Investment subscription agreements, and (iii) incorrect application of ASC 480 for common stock as permanent rather than temporary equity[183](index=183&type=chunk) - Remediation steps include expanding and improving the review process for complex securities and related accounting standards, with plans to enhance access to accounting literature and third-party professional consultation[184](index=184&type=chunk) [Part II. Other Information](index=37&type=section&id=Part%20II.%20Other%20Information) This part covers legal proceedings, risk factors, equity sales, defaults, mine safety, and other disclosures [Item 1. Legal Proceedings](index=37&type=section&id=Item%201.%20Legal%20Proceedings) This section details a lawsuit alleging breach of fiduciary duty and proxy statement deficiencies related to the Helbiz business combination - A lawsuit (Mohan v. GreenVision Acquisition Corp., et al.) was filed on **April 27, 2021**, alleging breach of fiduciary duty against the Board and material deficiencies in the proxy statement concerning the proposed business combination with Helbiz, Inc[187](index=187&type=chunk) - GreenVision believes the allegations are without merit and intends to vigorously defend the action[187](index=187&type=chunk) [Item 1A. Risk Factors](index=37&type=section&id=Item%201A.%20Risk%20Factors) This section refers to previously disclosed risk factors, confirming no material changes as of the current reporting date - Readers should refer to the risk factors in the Amendment No. 1 to Annual Report on Form 10-K/A for the year ended December 31, 2020[188](index=188&type=chunk) - As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in the aforementioned 10-K/A[188](index=188&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=37&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section reports no unregistered sales of equity securities or use of proceeds - No unregistered sales of equity securities and use of proceeds to report[189](index=189&type=chunk) [Item 3. Defaults Upon Senior Securities](index=37&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) This section reports no defaults upon senior securities - No defaults upon senior securities to report[190](index=190&type=chunk) [Item 4. Mine Safety Disclosures](index=37&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This section reports no mine safety disclosures - No mine safety disclosures to report[191](index=191&type=chunk) [Item 5. Other Information](index=37&type=section&id=Item%205.%20Other%20Information) This section reports no other information - No other information to report[192](index=192&type=chunk) [Item 6. Exhibits](index=37&type=section&id=Item%206.%20Exhibits) This section lists the exhibits filed as part of this Quarterly Report on Form 10-Q, including certifications and XBRL taxonomy documents - Exhibits include certifications of Principal Executive Officer and Principal Financial Officer (31.1, 31.2, 32.1, 32.2) and XBRL taxonomy documents (101.INS, 101.CAL, 101.SCH, 101.DEF, 101.LAB, 101.PRE, 104)[194](index=194&type=chunk) [Signatures](index=39&type=section&id=SIGNATURES) This section provides the official signatures of the Company's Chief Executive Officer and Chief Financial Officer, certifying the report - The report was signed by Salvatore Palella, Chief Executive Officer, and Giulio Profumo, Chief Financial Officer, on **August 23, 2021**[198](index=198&type=chunk)

Part I [Unaudited Financial Statements](index=4&type=section&id=Item%201.%20Unaudited%20Financial%20Statements) This section presents GreenVision Acquisition Corp.'s unaudited condensed consolidated financial statements for Q1 2021, covering balance sheet, operations, equity, and cash flows [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) As of March 31, 2021, total assets were **$59.2 million**, primarily marketable securities, with liabilities increasing to **$4.1 million** Condensed Consolidated Balance Sheet Highlights (unaudited) | Metric | March 31, 2021 | December 31, 2020 | | :--- | :--- | :--- | | **Assets** | | | | Cash | $169,151 | $4,282 | | Marketable securities held in Trust Account | $58,967,365 | $58,390,918 | | **Total Assets** | **$59,206,304** | **$58,413,629** | | **Liabilities & Equity** | | | | Total Liabilities | $4,116,304 | $3,411,210 | | Common stock subject to possible redemption | $50,089,995 | $50,002,415 | | Total Stockholders' Equity | $5,000,005 | $5,000,004 | [Condensed Consolidated Statement of Operations](index=5&type=section&id=Condensed%20Consolidated%20Statement%20of%20Operations) For Q1 2021, the company reported a net loss of **$487,419**, a reversal from prior-year net income, driven by operating costs and warrant liability changes Statement of Operations Summary (unaudited) | Metric | Three Months Ended March 31, 2021 | Three Months Ended March 31, 2020 | | :--- | :--- | :--- | | Operating and formation costs | $269,292 | $156,889 | | Interest earned on marketable securities | $1,448 | $325,611 | | Change in fair value of warrant liability | ($219,575) | $429,775 | | **Net income (loss)** | **($487,419)** | **$563,065** | | **Basic and diluted net income (loss) per common share** | **($0.22)** | **$0.16** | [Condensed Consolidated Statement of Changes in Stockholders' Equity](index=6&type=section&id=Condensed%20Consolidated%20Statement%20Changes%20in%20Stockholders%27%20Equity) Total stockholders' equity remained stable at **$5.0 million** for Q1 2021, influenced by a net loss and an extension fee contribution - Total stockholders' equity remained flat at approximately **$5.0 million** as of March 31, 2021, compared to January 1, 2021[16](index=16&type=chunk) - Key changes during the quarter included a net loss of **$487,419** and an extension fee contribution of **$575,000**[16](index=16&type=chunk) [Condensed Consolidated Statement of Cash Flows](index=7&type=section&id=Condensed%20Consolidated%20Statement%20of%20Cash%20Flows) Net cash used in operations was **$319,066**, offset by **$1,058,935** from financing activities, resulting in a **$164,869** net cash increase for Q1 2021 Cash Flow Summary (unaudited) | Metric | Three Months Ended March 31, 2021 | | :--- | :--- | | Net cash used in operating activities | ($319,066) | | Net cash provided by investing activities | ($575,000) | | Net cash provided by financing activities | $1,058,935 | | **Net Change in Cash** | **$164,869** | | **Cash – Ending** | **$169,151** | [Notes to Unaudited Condensed Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Unaudited%20Condensed%20Consolidated%20Financial%20Statements) These notes detail accounting policies, SPAC operations, merger agreements, related party transactions, and significant liquidity concerns, including going concern doubts - The company is a SPAC formed to effect a business combination, focusing on life sciences and healthcare industries outside of China[22](index=22&type=chunk)[23](index=23&type=chunk) - The company extended its combination period to May 21, 2021, by depositing **$575,000** into the Trust Account, funded by a transaction deposit from Helbiz[37](index=37&type=chunk) - Subsequent to quarter end, on May 12, 2021, the combination period was further extended to August 19, 2021, triggering redemption of **3,838,447 shares** for approximately **$39.2 million**, leaving **$19.5 million** in the trust account[39](index=39&type=chunk)[134](index=134&type=chunk) - Management concluded that conditions raise substantial doubt about the Company's ability to continue as a going concern through August 19, 2021, if a Business Combination is not consummated[49](index=49&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=29&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses Q1 2021 financial performance, including a net loss, merger developments, liquidity challenges, and a restatement related to warrant classification - The company terminated its merger agreement with Accountable Healthcare America, Inc. (AHA) on November 24, 2020, and is entitled to a break-up fee of **$3,175,000**, though receipt is not determinable[138](index=138&type=chunk) - On February 8, 2021, the company entered into a merger agreement with Helbiz, Inc., with an agreed valuation of **$300 million**, subject to adjustments for net debt[139](index=139&type=chunk) - The company restated its historical financial results to reclassify its Private Warrants as derivative liabilities instead of equity, impacting the financial statements[144](index=144&type=chunk) - As of March 31, 2021, the company had only **$169,151** of cash held outside the Trust Account for working capital, raising substantial doubt about its ability to continue as a going concern through its August 19, 2021 deadline[153](index=153&type=chunk)[156](index=156&type=chunk) [Quantitative and Qualitative Disclosures Regarding Market Risk](index=35&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20Regarding%20Market%20Risk) The company's investments in short-term U.S. government treasury securities and money market funds result in no material interest rate risk exposure - The company's investments are held in short-term U.S. government treasury securities or money market funds, minimizing material exposure to interest rate risk[168](index=168&type=chunk) [Controls and Procedures](index=35&type=section&id=Item%204.%20Controls%20and%20Procedures) Disclosure controls were ineffective as of March 31, 2021, due to a material weakness in warrant classification, with remediation efforts underway - Disclosure controls and procedures were deemed ineffective as of March 31, 2021[170](index=170&type=chunk) - The ineffectiveness was due to a material weakness related to the misclassification of Private Warrants as equity instead of derivative liabilities[170](index=170&type=chunk) - Remediation steps are being implemented, including an improved review process for complex securities and accounting standards[171](index=171&type=chunk) Part II. Other Information [Legal Proceedings](index=37&type=section&id=Item%201.%20Legal%20Proceedings) A lawsuit was filed on April 27, 2021, alleging breach of fiduciary duty and a deficient proxy statement related to the Helbiz merger - A lawsuit was filed against the company and its Board of Directors on April 27, 2021, related to the proposed merger with Helbiz[175](index=175&type=chunk) - Allegations include breach of fiduciary duty and a materially deficient proxy statement; the plaintiff seeks to enjoin the merger or recover damages[175](index=175&type=chunk) [Risk Factors](index=37&type=section&id=Item%201A.%20Risk%20Factors) No material changes to risk factors have occurred since the amended 10-K/A filing for the year ended December 31, 2020 - There have been no material changes to the company's risk factors since the filing of its amended 10-K/A for the year ended December 31, 2020[176](index=176&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=37&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) No unregistered sales of equity securities or use of proceeds were reported during the period - None[177](index=177&type=chunk) [Defaults Upon Senior Securities](index=37&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) No defaults upon senior securities were reported during the period - None[178](index=178&type=chunk) [Mine Safety Disclosures](index=37&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This item is not applicable as the company is not involved in mine operations - None[179](index=179&type=chunk) [Other Information](index=37&type=section&id=Item%205.%20Other%20Information) No other information required to be disclosed under this item was reported - None[180](index=180&type=chunk) [Exhibits](index=37&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the 10-Q, including SOX certifications and XBRL data files - Exhibits filed include CEO and CFO certifications (31.1, 31.2, 32.1, 32.2) and XBRL Instance Documents[182](index=182&type=chunk) Part III. Signatures

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Registration No. 33-234282 GREENVISION ACQUISITION CORPORATION (Exact Name of Registrant as Specified in Its Charter) | Delaware | | --- | (State or other jurisdic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39136 GREENVISION ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporatio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39136 Delaware 84-3015108 (State or other jurisdiction of incorporation or organization) One Penn Plaza, 36 Floor New York, NY 10019 (Addres ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39136 GREENVISION ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporation or ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Registration No. 33-234282 GREENVISION ACQUISITION CORPORATION (Exact Name of Registrant as Specified in Its Charter) | Delaware | 84-3015108 | | --- | --- | | (St ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) For the transition period from to Commission file number: 001-39136 GREENVISION ACQUISITION CORPORATION (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorp ...